CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 146 enrolled
Drug / intervention
Continuous glucose monitor +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00760526
NCT00760526Phase 3Completed
CompareCT.gov

A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children (4 to <10 Year Olds)

Jaeb Center for Health Research·interventional·Posted Sep 26, 2008·Updated Oct 19, 2016

In Brief

A Phase 3 clinical trial evaluating Continuous glucose monitor and Home blood glucose monitor for Diabetes Mellitus, Type 1. Completed, enrolled 146 participants across 5 sites.

Detailed Summary

The purpose of this study is to determine the efficacy, tolerability, safety, and effect on quality of life of CGM in children 4 to less than 10 years of age with type 1 diabetes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 1
CountriesUnited States
CollaboratorsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Timeline

Phase 3CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 26, 2008
Enrollment StartSep 1, 2010
Primary CompletionJun 1, 2011
Study CompletionJan 1, 2012
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 17.8 years ago

Interventions

Continuous glucose monitordevice

Daily use of a continuous glucose monitor

Home blood glucose monitordevice

Home monitoring 3 or more times a day